PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Sinclair & Co.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

OSO BioPharmaceuticals Invests $5 Million in Aseptic Filling Suite - State-of-the-art filling line will increase capacity and yield of liquid, suspension and lyophilized products - OSObio.com
OSO BioPharmaceuticals Invests $5 Million in Aseptic Filling Suite

 

NewswireToday - /newswire/ - Albuquerque, NM, United States, 2012/04/30 - State-of-the-art filling line will increase capacity and yield of liquid, suspension and lyophilized products - OSObio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

OSO BioPharmaceuticals Manufacturing, LLC is investing more than $5 million in equipment and infrastructural improvements that include a new Grade A aseptic filling suite for liquid, suspension and lyophilized products.

The rolling diaphragm pump filling suite, manufactured by Bosch, comes equipped with optional rotary piston and peristaltic pumps. It will function at 115 percent of the previous line’s capacity, increasing the speed and efficiency with which OsoBio can deliver drug products to clients.

Thanks to its ability to conduct non-destructive online weight tests, the new line will deliver greater precision and yield. And its restricted access barrier system will minimize risk of cross-contamination and diminish potential occupational exposure.

OsoBio is a contract manufacturing organization (CMO) that produces injectable sterile liquids, suspension and lyophilized biologic and pharmaceutical products for the pharmaceutical industry.

“This state-of-the-art filling suite represents a substantial investment in the future – the future of OsoBio, as well as the futures of the pharmaceutical clients we serve,” said Milton Boyer, president. “It allows OsoBio to manufacture drugs in a better, smarter and faster manner, while ensuring high-quality product and the safety of patients and employees alike. This is an exciting new addition to OsoBio’s facility.”

In preparation for the new line, OsoBio extensively remodeled its facility, making infrastructural enhancements that included installing welded PVC walls throughout controlled and classified areas to further secure the sterile environment and improve durability, ease of use and maintenance. OsoBio also installed poured epoxy floors throughout its facility to support its strong record of industrial safety.

The new line produces sterile liquid, suspension and lyophilized formulations in vial sizes ranging from 2cc to 100cc. The Bosch equipment includes:

• An RRU 3084/44 high-performance container washing machine, which uses intensive flooding, ultrasonic and spraying techniques to reliably clean vials inside and out in a continuous process,

• An HQL 4480S drying and sterilization tunnel with laminar flow for depyrogenization and cooling of glass vials,

• An FLC 3080 filling and closing machine designed to fill, sample check-weigh and stopper vials in a continuous motion process in compliance with International Organization for Standardization requirements,

• A GLT 4040 tray loader with 100-percent vial counting accuracy, and

• A TRL 1030 tray loader designed to automatically load vials at high speed in cleanroom applications, requiring minimal interaction and maintaining Good Manufacturing Practices (GMP) standards.

OsoBio’s new filling suite should be installed, fully validated and operational by late August.

Headquartered in Albuquerque, N.M., OsoBio (osobio.com) specializes in products requiring complex handling, including highly potent compounds. Responsiveness, attention to detail and clear communication are the hallmarks of our client care.

OsoBio surpasses quality-assurance expectations within our industry. Our employees are industry veterans who provide innovative solutions to our clients’ most difficult projects.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Sinclair & Co.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


OSO BioPharmaceuticals Invests $5 Million in Aseptic Filling Suite

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Karen Stinneford - Sinclair-Co.com 
919-833-9102 kstinneford[.]sinclair-co.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sinclair & Co. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Sinclair & Co. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Intrinsic Executive Search Ltd

Visit  Al Rowaad Advocates & Legal Consultants





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)